# An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

> **NCT02496546** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 30 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** LEO 32731 cream
- **DRUG:** LEO 32731 cream vehicle

## Key facts

- **NCT ID:** NCT02496546
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496546, "An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02496546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*